Why Bank Umbilical Cord Lining

Complete health protection for your child and family

When you bank the umbilical cord lining, you are banking the stem cells found in it. The patented technology available at Cordlife allows the isolation of Epithelial Stem Cells (EpSCs) and Mesenchymal Stem Cells (MSCs),two types of stem cells found in the umbilical cord lining but not present in umbilical cord blood.

Storing both umbilical cord blood and umbilical cord lining will allow maximum recovery of all types of stem cells, thus increasing one’s options for possible therapeutic applications in the future. The patented technology provided by Cordlife allows isolation and expansion of EpSCs and MSCs, two types of stem cells found in the umbilical cord lining but not present in cord blood.

By storing a combination of HSCs, MSCs and EpSCs, you are availing your child to be part of a medical revolution with the access to the growing applications of stem cells and the therapeutic potential that they hold. These cells, being able to be collected at birth only, are the youngest and most potent cells available.

Here are 6 top reasons why you should consider umbilical cord lining banking for your baby:

  1. Umbilical cord lining stem cells have immune-modulating characteristics. Therefore matching of stem cells between donor and the patient may not be required, which makes them useful both for your baby and other members in the family;
  2. Umbilical cord lining stem cells can also help increase the success rate of stem cell transplant. It contains two types of stem cells – Mesenchymal (MSCs) and Epithelial (EpSCs) Stem Cells, which can be used to support multiple medical treatments whenever needed.
  3. With umbilical cord lining stem cells, your baby and family members will have more treatment options in the future, especially for disorders* that are incurable today such as stroke and heart attack.
  4. Compared to other sources such as bone marrow and adipose tissue, stem cells from umbilical cord lining are younger with better expansion capacity and patients receiving such as stem cells have lower risk of graft versus host disease.
  5. Using cryogenic storage method, umbilical cord lining can remain viable for a long time. This means that the therapeutic value of umbilical cord lining stem cells are well-preserved until the need for treatment arises.
  6. Your baby has one chance to have his/her umbilical cord lining collected as this painless and harmless process must be done at birth.

Potential therapy with umbilical cord lining stem cells

MSCs and EpSCs are currently being evaluated in more than 700 clinical trials1 for the treatment of medical conditions including heart disease, stroke, spinal cord injury, cornea repair as well as wound healing such as burns and diabetic ulcers. The table outlines some of the potential applications with MSCs and EpSCs. As clinical research continues to take place globally, this list will continue to grow with time.

Cordlife's Exclusive: Epithelial stem cells (EpSCs)

Disorders investigated in MSCs Clinical Trials


Tissue Repair
  • Stroke
  • Heart failure
  • Alzheimer’s disease
  • Parkinson’s disease
  • Spinal cord injury
  • Orthopaedic indications (bone, cartilage, tendon repair)
  • Liver Failure

Immune Modulation or reconstitution
  • HIV
  • Type 1 diabetes
  • Graft versus host disease (GvHD)

HSCs engraftment support
  • Shorten time of engraftment
  • Reduce immune system complications

Disorders investigated in EpSCs Clinical Trials


Soft Tissue Repair
  • Skin wounds
  • Ocular surface disorders
  • Persistent epithelial defect
  • Replacement of insulin-producing cells for diabetic patients
  • Haemophilia


Sources:
1. https://www.clinicaltrials.gov/ct2/results?term=mesenchymal+stem+cells&Search=Search. Last accessed November 2017.

Request A Call Back